MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Merck to invest up to $17M in Physicians Interactive | Funding Roundup

Merck to invest up to $17M in Physicians Interactive | Funding Roundup

By

Mela

Merck Global Health Innovation Fund will invest up to $17 million in medical app maker Physicians Interactive Holdings. The financing includes $8.5 million up front, but could double if the mHealth marketer meets Merck’s milestones.

The Marlborough, Mass.-based company plans to use the Merck funds to grow "4 key products," including its flagship medical resources app Skyscape.

The app, which it acquired in mid-2009, accounts for nearly 90% of its health care division. Skyscape is a clinical decision and educational application marketed to doctors, health care workers, teachers and medical students.

Sign up to get our free newsletters delivered right to your inbox

"We are excited by this investment from Merck Global Health Innovation Fund and it validates both our achievements to-date and the compelling vision around our innovative programs for healthcare professionals and life science companies. This investment will allow us to further expand our internal product development and customer solutions, as well as explore new markets and additional customer segments," Physicians Interactive Holdings’ CEO Donato Tramuto said in prepared remarks.

Along with its $8.5 million in funding, Merck’s GHIF will appoint 1 of their executives to the Physicians Interactive board of directors.

Funding

Here’s a roundup of other dealflow and investment news:

Cowen Healthcare Royalty Partners raises $1B
Global health care investment firm Cowen Healthcare Royalty Partners raised approximately $1 billion, exceeding the target by more than 75%. Read more

Avinger lands $22.5M in Series C
Wildcat and Kittycat catheter maker Avinger Inc. closed a $22.5 million Series C funding round. Avinger plans to use the funds to further the U.S. and European commercialization of its catheters used to treat peripheral artery disease. Read more

Echo Therapeutics announces $3.6M warrant exercise
Echo Therapeutics received $3.6M in warrant exercises. These exercises bring the company’s year-end cash balance to $9.2 million. Read more

Cardiac catheter maker aims for $2.5M
Hypertension catheter system company Ablative Solutions raised slightly more than 1/3 of its $2.5 million target in a Series A financing round. Read more

Uptake sells $35M in public offering
Uptake Medical Corp. sold $35.1 million of a target $41.6 million in a public offering finance round, according to an SEC filing. Read more

Ophthalmic startup raises $2M
Med-tech startup Corinthian Ophthalmic raised $2.2 million from 11 investors to fund its quest to replace the standard eyedropper. Read more

CytoPherx raises $34M for U.S. clinical trials
Ann Arbor, Mich.-based CytoPherx completed a $34 million funding round to help fund clinical trials for its continuous renal replacement therapy. The round was led by Early Stage Partners, ONSET Ventures and Capital Midwest Fund. Read more

GlySure secures $10.9M in Series C
Glucose monitoring system maker GlySure secured $10.9 million in funding from venture capital firms in a Series C financing round. The Oxford, England-based company plans to use the funding to support clinical trials in the U.S. and Europe. Read more

Cardiovascular Systems amends agreement with SVB
Cardiovascular Systems Inc. amended a loan & security agreement with Silicon Valley Bank to provide the company with $2 million more capital, increasing the loan terms from $10 million to $12 million. Read more

CircLite wins $950,000 grant
CircuLite Inc. landed a $950,000 grant from the Cardiovascular Medical Research & Education Fund. The money will support the Saddle Brook, N.J.-based company’s Synergy micro-pump. Read more

Neoprobe secures $10M
Dublin, Ohio-based Neoprobe Corp. landed $10 million in debt financing from life sciences fund Hercules Technology II. Read more

MiMedx sells notes for $5M
MiMedx sold 5% convertible senior promissory notes to 13 accredited investors for $5 million. The notes matures on Dec. 31, 2013 and bear 5% interest. Read more

Clearside Biomedical lands $4M in Series A
Ophthalmic startup Clearside Biomedical landed $4 million in a Series A venture financing round to fund the initial development of the company’s ocular microinjection platform that delivers drugs to the back of the eye. Read more

In case you missed it

RSS From Medical Design & Outsourcing

  • Stryker launches a smart hospital bed
    Stryker (NYSE:SYK) announced this week that it launched the ProCuity wireless smart hospital bed to improve efficiency and safety while lowering costs. The intelligent bed was designed to help reduce in-hospital patient falls at all acuity levels while also improving nurse workflow efficiencies and safeties at lesser cost to the hospital. Stryker said in a news… […]
  • West Pharmaceuticals dips despite strong Q3, raised guidance
    West Pharmaceutical Services (NYSE:WST) shares dipped slightly despite third-quarter results that topped the consensus forecast. The Exton, Pa.-based company posted profits of $82.3 million, or $1.09 per share, on sales of $548 million for the three months ended Sept. 30, 2020, for a 46.2% bottom-line gain on sales growth of 0.3%. Get the full story at… […]
  • Level Ex builds virtual bridge to span medical device divide
    With COVID-19 shutting down clinical meetings and closing operating room doors to sales reps, medical device manufacturers are searching for new ways to support surgeons and physicians using their devices. Level Ex, maker of a video game system, this week shared how it will help bridge this device divide, rolling out its Virtual Technique Guides,… […]
  • Interpower to produce Virtual Global Trade Show Booth
    Interpower (Oskaloosa, Iowa) — an electrical power cord and component manufacturer — plans to launch its Virtual Trade Show Booth on Oct. 27. The idea is to connect with its customers as well as industry professionals. This Virtual Booth launch comes after a year of quarantines and travel restrictions which prompted show postponements and cancellations.… […]
  • Are Stephen Hahn’s days numbered at FDA?
    HHS Secretary Alex Azar has been reportedly discussing the removal of Dr. Stephen Hahn as FDA commissioner, according to Politico. The Politico report cited a half dozen current and former administration officials. FDA spokesperson Michael Felberbaum in an email to Medical Design & Outsourcing‘s sister site MassDevice denied an Azar-Hahn feud: “Commissioner Hahn enjoys a… […]
  • Applied VR gains FDA breakthrough device nod
    AppliedVR announced that it received FDA breakthrough device designation for its fibromyalgia and lower back pain treatment. Los Angeles-based AppliedVR’s EaseVRx product is designed to treat treatment-resistant fibromyalgia and chronic intractable lower back pain. With the breakthrough nod, EaseVRx is now one of the first virtual reality (VR) digital therapeutics to earn that designation for… […]
  • DeviceTalks Tuesdays: Creativity in Engineering Design: Things I Was Never Taught In Engineering School
    Tuesday, Oct. 27, 2020 4 pm Eastern Tim/ 1 pm Pacific Time Engineering is an act of creation – a lot of folks get into this line of work explicitly because they want to create. In this webinar, speakers will talk about the light bulb moments of lone inspiration, and the more practical group efforts.… […]
  • Acuitive Technologies wins FDA clearance for tendon interference screw system
    Acuitive Technologies announced today that it received FDA 510(k) clearance for its CitreLock interference screw system. CitreLock with CitreGen material technology, a next-generation thermoset bioresorbable synthetic polymer, is designed to attach tissue during orthopedic surgeries, including the fixation of ligaments or tendon graft tissue repairs of the shoulder, elbow, wrist, hand, knee and foot extremities,… […]
  • Medovate lands distro deal with major French medtech company
    Medtech manufacturer Vygon Group recently announced that it will distribute Medovate’s SAFIRA (SAFer Injection for Regional Anaesthesia) device across 60 countries. Developed in collaboration with UK National Health Service clinicians, SAFIRA is designed to transform the technique of peripheral nerve blockade into a one-person procedure, giving the anaesthetist full control of the injection at all… […]
  • How spider webs could inspire better biomedical imaging
    Researchers at Purdue University are today touting the use of architectural features from spider webs in biomedical imaging. As spider webs usually provide strong mechanical adaptability and damage-tolerance against various mechanical loads, such as storms, they are coming in handy in the development of 3D photodetectors for use in biomedical imaging, according to a news… […]
  • DTW Podcast: Who will win medtech’s own Supreme Court fight; and can the many mini Medtronics plan work?
    In this week’s DeviceTalks Weekly podcast, we’ll first delve into Medtech’s own brewing Supreme Court battle. J. Michael Jakes, a partner at Finnegan, will tell us why the industry should be watching when the Supremes review the latest patent battle between Arthrex and Smith+Nephew. We’ll also talk about Medtronic’s Analyst Meeting where CEO Geoff Martha and the team… […]

Leave a Reply